Pharmaron Beijing Statistics

Total Valuation

Pharmaron Beijing has a market cap or net worth of CNY 45.09 billion. The enterprise value is 48.97 billion.

Market Cap	45.09B
Enterprise Value	48.97B

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	Jun 27, 2024

Share Statistics

Pharmaron Beijing has 1.78 billion shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	n/a
Shares Outstanding	1.78B
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.35%
Owned by Insiders (%)	7.79%
Owned by Institutions (%)	42.59%
Float	1.14B

Valuation Ratios

The trailing PE ratio is 26.29 and the forward PE ratio is 28.48. Pharmaron Beijing's PEG ratio is 3.24.

PE Ratio	26.29
Forward PE	28.48
PS Ratio	4.19
PB Ratio	3.69
P/TBV Ratio	4.63
P/FCF Ratio	133.82
P/OCF Ratio	n/a
PEG Ratio	3.24

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.35, with an EV/FCF ratio of 132.07.

EV / Earnings	25.99
EV / Sales	4.15
EV / EBITDA	19.35
EV / EBIT	32.93
EV / FCF	132.07

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.42.

Current Ratio	1.71
Quick Ratio	1.32
Debt / Equity	0.42
Debt / EBITDA	2.31
Debt / FCF	15.75
Interest Coverage	6.16

Financial Efficiency

Return on equity (ROE) is 13.58% and return on invested capital (ROIC) is 4.79%.

Return on Equity (ROE)	13.58%
Return on Assets (ROA)	4.04%
Return on Capital (ROIC)	4.79%
Revenue Per Employee	581,178
Profits Per Employee	92,824
Employee Count	20,295
Asset Turnover	0.51
Inventory Turnover	7.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.74% in the last 52 weeks. The beta is 0.87, so Pharmaron Beijing's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	-4.74%
50-Day Moving Average	28.69
200-Day Moving Average	22.89
Relative Strength Index (RSI)	47.38
Average Volume (20 Days)	25,780,053

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmaron Beijing had revenue of CNY 11.80 billion and earned 1.88 billion in profits. Earnings per share was 1.06.

Revenue	11.80B
Gross Profit	4.02B
Operating Income	1.49B
Pretax Income	2.14B
Net Income	1.88B
EBITDA	2.34B
EBIT	1.49B
Earnings Per Share (EPS)	1.06

Full Income Statement

Balance Sheet

The company has 2.60 billion in cash and 5.84 billion in debt, giving a net cash position of -3.24 billion or -1.82 per share.

Cash & Cash Equivalents	2.60B
Total Debt	5.84B
Net Cash	-3.24B
Net Cash Per Share	-1.82
Equity (Book Value)	14.03B
Book Value Per Share	7.57
Working Capital	2.94B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.49 billion and capital expenditures -2.12 billion, giving a free cash flow of 370.77 million.

Operating Cash Flow	2.49B
Capital Expenditures	-2.12B
Free Cash Flow	370.77M
FCF Per Share	0.21

Full Cash Flow Statement

Margins

Gross margin is 34.12%, with operating and profit margins of 12.61% and 15.97%.

Gross Margin	34.12%
Operating Margin	12.61%
Pretax Margin	18.13%
Profit Margin	15.97%
EBITDA Margin	19.88%
EBIT Margin	12.61%
FCF Margin	3.14%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.72%.

Dividend Per Share	0.20
Dividend Yield	0.72%
Dividend Growth (YoY)	-33.33%
Years of Dividend Growth	n/a
Payout Ratio	29.13%
Buyback Yield	-0.06%
Shareholder Yield	0.66%
Earnings Yield	3.80%
FCF Yield	0.75%

Dividend Details

Stock Splits

The last stock split was on July 27, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 27, 2023
Split Type	Forward
Split Ratio	1.5

Scores

Pharmaron Beijing has an Altman Z-Score of 3.7.

Altman Z-Score	3.7
Piotroski F-Score	n/a